Bristol Myers Squibb Other Operating Income or Expenses 2010-2024 | BMY
Bristol Myers Squibb other operating income or expenses for the twelve months ending June 30, 2024 were $275M, a 68.96% decline year-over-year.
- Bristol Myers Squibb annual other operating income or expenses for 2023 were $1.158B, a 301.04% decline from 2022.
- Bristol Myers Squibb annual other operating income or expenses for 2022 were $-0.576B, a 180% decline from 2021.
- Bristol Myers Squibb annual other operating income or expenses for 2021 were $0.72B, a 68.89% decline from 2020.